Bleeding Disorder Treatments: von Willebrand Disease

Share this content:
BLEEDING DISORDER TREATMENTS: VON WILLEBRAND DISEASE
BLEEDING DISORDER TREATMENTS: VON WILLEBRAND DISEASE
Brand Strength Form Dose
ANTIHEMOPHILIC FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
Alphanate1 250 IU, 500 IU, 1000 IU, 1500 IU lyophilized pwd for IV inj after reconstitution Adults: Pre-op: 60 VWF:RCo IU/kg, then 40–60 VWF:RCo IU/kg every 8–12hrs if needed; may reduce dose after 3rd post-op day; treat until healed. Max infusion rate ≤10mL/min.
Children: Initially 75 VWF:RCo IU/kg, then 50–75 VWF:RCo IU/kg every 8–12hrs if needed; may reduce dose after 3rd post-op day; treat until healed. Max infusion rate ≤10mL/min.
Humate-P 250 IU FVIII + 600 IU VWF, 500 IU FVIII + 1200 IU VWF, 1000 IU FVIII + 2400 IU VWF lyophilized pwd for IV infusion after reconstitution Adults and Children: Type 1 (Mild): major bleed: initially 40–60 IU/kg, then 40–50 IU/kg every 8–12hrs for 3 days, then once daily for a total of 7 days. Type 1 (Moderate or severe): minor bleed: 40–50 IU/kg for 1–2 doses; major bleed: initially 50–75 IU/kg, then 40–60 IU/kg every 8–12hrs for 3 days, then once daily for a total of 7 days. Types 2 and 3: minor bleed: 40–50 IU/kg for 1–2 doses; major bleed: initially 60–80 IU/kg, then 40–60 IU/kg every 8–12hrs for 3 days, then once daily for a total of 7 days. Max infusion rate: 4mL/min. Surgery: see full labeling.
Wilate 500 IU FVIII + 500 IU VWF:RCo, 1000 IU FVIII + 1000 IU VWF:RCo pwd for IV inj after reconstitution <5yrs: Contact manufacturer.
≥5yrs: Minor bleed: 20–40 IU/kg once, then 20–30 IU/kg every 12–24hrs as needed. Major bleed: 40–60 IU/kg once, then 20–40 IU/kg every 12–24hrs as needed. Surgery (give loading dose within 3hrs before); Minor: 30–60 IU/kg once, then 15–30 IU/kg every 12–24hrs; Major: 40–60 IU/kg once, then 20–40 IU/kg every 12–24hrs. Usual duration: minor hemorrhage/surgery: 3 days; major hemorrhage: 5–7 days; major surgery: ≥6 days.
DESMOPRESSIN
Stimate2 150mcg/spray soln for nasal spray Adults and Children: <11mos: not recommended. Give test dose prior to initiation. >11mos: <50kg: 1 spray in one nostril (150mcg). ≥50kg: 1 spray per nostril (300mcg). May repeat dose based on clinical response. Pre-op: give 2hrs prior to procedure.
VON WILLEBRAND FACTOR
Vonvendi3 650 IU VWF:RCo, 1300 IU VWF:RCo lyophilized pwd for IV inj after reconstitution Adults: ≥18yrs: Minor bleed: initially 40–50 IU/kg, then every 8–24hrs as needed. Major bleed: initially 50–80 IU/kg, then 40–60 IU/kg every 8–24hrs for 2–3 days as needed. Max infusion rate: 4mL/min. Surgery: see full labeling.
Children: <18yrs: not established.
NOTES

Key: FVIII = Factor VIII; VWF = von Willebrand factor; VWF:RCo = von Willebrand factor Ristocetin cofactor

1 Not for severe VWD (Type 3) undergoing major surgery.

2 For mild-moderate Type 1 VWD with Factor VIII >5% only.

3 Give recombinant FVIII with first infusion if baseline plasma FVIII level <40% or is unknown. Recombinant FVIII may also be needed for subsequent infusions or prior to surgery.

Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling.

(Created 4/2018)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs